David S Huang

4PUBLICATIONS
12CO-AUTHORS
Gene and molecular therapyCheminformatics and quantitative structure-activity relationshipsMolecular medicineToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 13, 2025
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers.

Rishi G Vaswani, David S Huang, Neville Anthony

|Jan 14, 2021
Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity.

Paul T Marcyk, Emmanuelle V LeBlanc, Douglas A Kuntz

|Sep 13, 2019
Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors.

David S Huang, Emmanuelle V LeBlanc, Tanvi Shekhar-Guturja

|Jan 30, 2019
Identification of the Metabolic Profile of the α-Tubulin-Binding Natural Product (-)-Pironetin.

Sara K Coulup, David S Huang, Henry L Wong

Pageof 1

Frequent Collaborators

2 joint publications

Lauren E Brown

1 joint publications

Sara K Coulup

1 joint publications

Henry L Wong

1 joint publications

Gunda I Georg